Elevation Oncology, Inc.
ELEV · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $15,332 | $33,262 | $35,459 | $168,792 |
| - Cash | $60,494 | $49,464 | $48,202 | $59,447 |
| + Debt | $31,253 | $31,134 | $31,021 | $30,916 |
| Enterprise Value | -$13,909 | $14,932 | $18,278 | $140,261 |
| Revenue | $0 | $38 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$5 | $19 | -$5 | -$4 |
| % Margin | – | 50% | – | – |
| EBITDA | -$14,216 | -$9,464 | -$13,224 | -$10,959 |
| % Margin | – | -24,905.3% | – | – |
| Net Income | -$14,211 | -$10,436 | -$12,881 | -$10,461 |
| % Margin | – | -27,463.2% | – | – |
| EPS Diluted | -0.24 | -0.18 | -0.22 | -0.18 |
| % Growth | -33.3% | 18.2% | -22.2% | – |
| Operating Cash Flow | -$12,711 | -$10,202 | -$8,382 | -$8,205 |
| Capital Expenditures | $0 | $0 | -$8,205 | $8,205 |
| Free Cash Flow | -$12,711 | -$10,202 | -$8,382 | $0 |